employed an ELISA kit to quantify plasma Osteopontin levels in patients diagnosed with HNSCC who underwent platinum‐based chemoradiotherapy prior to and post‐treatment completion. The gene discussed is SPP1; the disease is head and neck squamous cell carcinoma.